Skip to main content
Erschienen in: Critical Care 3/2010

01.06.2010 | Commentary

To dose or not to dose: that is the (starch) question ...

verfasst von: Lewis J Kaplan

Erschienen in: Critical Care | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The present study describes the impact on renal function of a modern starch used for resuscitation in the intensive care unit. The role of starch in renal dysfunction, the importance of the definition of acute kidney injury and acute renal failure, and hyperoncoticity are reviewed.
Literatur
1.
Zurück zum Zitat Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Georges H, Leroy O: Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010, 14: R40. 10.1186/cc8920PubMedCentralCrossRefPubMed Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Georges H, Leroy O: Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010, 14: R40. 10.1186/cc8920PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL: Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007, 98: 216-224. 10.1093/bja/ael333CrossRefPubMed Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL: Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007, 98: 216-224. 10.1093/bja/ael333CrossRefPubMed
3.
Zurück zum Zitat Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hernery F, Lemaire F, Brochard L: Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001, 357: 911-916. 10.1016/S0140-6736(00)04211-2CrossRefPubMed Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hernery F, Lemaire F, Brochard L: Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001, 357: 911-916. 10.1016/S0140-6736(00)04211-2CrossRefPubMed
4.
Zurück zum Zitat Brunkhorst FM, Engel C, Bloos F, Meir-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschincki U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhunt E, Kiehntopf M, Hartog C, Nathanson C, Loeffler M, Rainhart K, German Competence Network Sepsis (SepNet): Intensive inslin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358: 125-139. 10.1056/NEJMoa070716CrossRefPubMed Brunkhorst FM, Engel C, Bloos F, Meir-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschincki U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhunt E, Kiehntopf M, Hartog C, Nathanson C, Loeffler M, Rainhart K, German Competence Network Sepsis (SepNet): Intensive inslin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358: 125-139. 10.1056/NEJMoa070716CrossRefPubMed
5.
Zurück zum Zitat Honore PM, Joannes-Boyau O, Boer W: Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order? Intensive Care Med 2008, 34: 2127-2129. 10.1007/s00134-008-1226-1CrossRefPubMed Honore PM, Joannes-Boyau O, Boer W: Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order? Intensive Care Med 2008, 34: 2127-2129. 10.1007/s00134-008-1226-1CrossRefPubMed
6.
Zurück zum Zitat Schortgen F, Girou E, Deye N, Brochard L, CRYCO Study Group: The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008, 34: 2157-2168. 10.1007/s00134-008-1225-2CrossRefPubMed Schortgen F, Girou E, Deye N, Brochard L, CRYCO Study Group: The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008, 34: 2157-2168. 10.1007/s00134-008-1225-2CrossRefPubMed
7.
Zurück zum Zitat Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, ADQI workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8: R204-R212. 10.1186/cc2872PubMedCentralCrossRefPubMed Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, ADQI workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8: R204-R212. 10.1186/cc2872PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG: Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999, 88: 992-998. 10.1097/00000539-199905000-00005PubMed Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG: Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999, 88: 992-998. 10.1097/00000539-199905000-00005PubMed
9.
Zurück zum Zitat Kellum JA, Cerda J, Kaplan LJ, Nadim MK, Palevsky PM: Fluids for prevention and management of acute kidney injury [review - ADQI Consensus Statement]. Int J Artif Organs 2008, 31: 96-110.PubMed Kellum JA, Cerda J, Kaplan LJ, Nadim MK, Palevsky PM: Fluids for prevention and management of acute kidney injury [review - ADQI Consensus Statement]. Int J Artif Organs 2008, 31: 96-110.PubMed
Metadaten
Titel
To dose or not to dose: that is the (starch) question ...
verfasst von
Lewis J Kaplan
Publikationsdatum
01.06.2010
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 3/2010
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc8973

Weitere Artikel der Ausgabe 3/2010

Critical Care 3/2010 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.